Title
Potentially serious drug interactions resulting from the pretravel health encounter
Date Issued
01 November 2018
Access level
open access
Resource Type
journal article
Author(s)
Sbaih N.
Buss B.
Goyal D.
Rao S.R.
Benefield R.
Walker A.T.
Esposito D.H.
Ryan E.T.
LaRocque R.C.
Leung D.T.
Abraham G.M.
Alvarez S.
Ansdell V.
Yates J.A.
Atkins E.H.
Birich H.K.
Vitek D.
Cahill J.
Chen L.
Connor B.A.
Dismukes R.
Fairley J.
Kozarsky P.
Wu H.
TravelWell E.
Dosunmu R.
Goad J.A.
Mirzaian E.
Higuita N.I.A.
Hess K.
Hynes N.A.
Jacquerioz F.
McLellan S.
Katsolis J.
Kelly P.
Knouse M.
Lee J.
Kendall B.
Hale D.V.
Oladele A.
Demeke H.
Oladele A.
Otuata A.
Pasinski R.
Wheeler A.E.
Showler A.
Coster L.
Rosen J.
Schwartz B.S.
Stauffer W.
Walker P.
University of California-San Diego School of Medicine
Publisher(s)
Oxford University Press
Abstract
Travelers seen for pretravel health encounters are frequently prescribed new travel-related medications, which may interact with their previously prescribed medications. In a cohort of 76 324 travelers seen at 23 US clinics, we found that 2650 (3.5%) travelers were prescribed travel-related medications with potential for serious drug interactions.
Volume
5
Issue
11
Language
English
OCDE Knowledge area
Ciencias de la salud
Subjects
Scopus EID
2-s2.0-85065067397
Source
Open Forum Infectious Diseases
Resource of which it is part
Open Forum Infectious Diseases
Source funding
Centers for Disease Control and Prevention
Sponsor(s)
Financial support. This work was supported by US Centers for Disease Control and Prevention Grants U19CI000514, U01CK000175, and U01CK000490. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Sources of information:
Directorio de Producción Científica
Scopus